News Releases
Bachem News & Events
Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.
More News Releases by Bachem
-
News Releases
Bachem Enters Strategic Collaboration With Lilly T
Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology.406465 05.10.22
-
News Releases
No More DMF: Greener Solid-Phase Peptide Synthesis
Register now for the webinar on Thursday, May 12th at 5:30pm CET / 8:30am PST.405047 04.20.22
-
News Releases
WEBINAR: The Use of Enzymes in the Production of P
Learn in this webinar how enzymes enable greener peptide syntheses and what questions appear around the use of enzymes in a GMP setting.403555 03.29.22
-
News Releases
-
News Releases
-
News Releases
Bachem reports excellent results for the first hal
Sales of CHF 500 million are now expected for the year 2021.388773 09.01.21
-
News Releases
Bachem and Novo Nordisk Redesign SPPS for Green Ch
Replacing gold standard solvents to provide a greener alternative.388206 08.24.21
-
News Releases
Propofol – A Bachem Success Story
The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.388215 08.24.21
More Content From Bachem
-
Risk Assessment for a Nitrosamine Contamination of Peptide APIs Manufactured by SPPS
This webinar will focus on Bachem's approach to execute the risk assessment for peptides produced by SPPSVideos Released on 05.25.2022
-
Bachem - Partner from Research to Marketed API
Bachem is the world’s leading company in the development and production of peptides and oligonucleotides (TIDES).Literature / Brochures Released on 05.10.2022
-
Bachem's New Facilities For Large-Scale Oligonucleotide Manufacturing Suppliers
Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.Company Blog Released on 04.20.2022
-
Cell-Penetrating Peptides: A Delivery System For Oligonucleotides
Oligonucleotides are very promising and versatile therapeutics for rare and genetic diseases.Literature / Brochures Released on 03.21.2022
-
Oligo Therapeuticas - Innovation that Transforms Lives
Welcome to the Future.Literature / Brochures Released on 03.09.2022
-
Oligonucleotides - Innovation that transforms lives
Emerging as a new treatment option in rare and orphan disease areas, oligonucleotides have matured into a drug class with a broad indication spectrum.Videos Released on 03.09.2022
-
Bachem - The Perfect Ingredients for a Better World
What ingredients make Bachem a world-leading specialist for drug substances and a partner for pharma & biotech across the globe?Videos Released on 03.09.2022
-
The thiol-maleimide reaction downside
Secrets of an important byproduct revealedCompany Blog Released on 03.04.2022
-
[WEBINAR] Trends in Peptides and Oligonucleotides – Choosing a Bartner CDMO
This webinar which will take you through the foreseeable future of peptides and oligonucleotides.Videos Released on 02.01.2022
-
Do it Right, by Not Doing it Yourself – the Value of a Good CDMO Partner
Partnering with a specialized CDMO can have many advantages especially for complex API like peptides or oligonucleotides.Videos Released on 01.03.2022
-
How are peptides made?
Peptides are very interesting molecules for many applications from therapeutics to cosmetics and diagnostics. But how are they made?Literature / Brochures Released on 10.06.2021
-
Bachem's Liraglutide: A High-Purity Generic for Diabetes and Weight Loss
Liraglutide, a so-called glucagon like peptide-1 (GLP-1) receptor agonist, is used for the treatment of Type 2 diabetes mellitus and obesity.Product Releases Released on 09.28.2021
-
Generic APIs from Bachem
Bachem covers the entire life cycle of an active pharmaceutical ingredient (API). View all of our generic APIs here.Product Releases Released on 08.12.2021
-
Microspheres and Nanoparticles for Peptide Delivery
The use of nanoparticles for delivering proteins and peptides are still in early stages of development and is expected to mature in the near future.Videos Released on 08.12.2021
